EpilepsyGTXListed
epilepsygtx.combiotech_life_sciences
EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).
Gesynta Pharma is a clinical stage pharmaceutical company developing innovative treatments by targeting mPGES-1, an important pro-inflammatory enzyme with a key role in endometrio…
iOnctura is a biopharmaceutical company focused on developing high impact, low disruption therapies for hard-to-treat cancers. The company aims to disrupt the tumor-stroma-immune…
Genespire is a biotechnology company that develops off-the-shelf gene therapies for pediatric patients affected by genetic diseases, focusing on innovative lentiviral vector techn…
Protembis is a privately held emerging medical device company that has developed the ProtEmbo® Cerebral Protection System, designed to protect patients from brain injury during le…
Tes Pharma is a biotech company focused on delivering first-in-class therapeutics for high unmet medical needs in oncology, renal diseases, and metabolic diseases. The company uti…
Nouscom is a next-generation immunotherapy company developing engineered viral vectored vaccines for treatment of cancer, utilizing proprietary platforms to induce strong immune r…
PAGE Therapeutics is a platform-based oncology drug development company focused on discovering and commercializing compounds that disrupt cell-cell adhesion in cancer cells to imp…
Dialybrid S.r.l. is a clinical-stage medical device company developing innovative vascular grafts for hemodialysis and other vascular applications. Its lead product, Silkothane® A…
NanoPhoria is a preclinical-stage biotech company pioneering the next generation of cardiovascular treatments through an innovative inhaled, Nano-in-Micro delivery platform. Our m…
AAVantgarde is a biotechnology company focused on gene therapies for inherited retinal diseases, developing large gene delivery platforms for therapeutic programs.